Avner Ingerman News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Avner Ingerman. Real-time updates on events, politics, business and more.

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2201 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

November 20, 2023

/PRNewswire/ -- Chengdu Origen Biotechnology Co., Ltd. ("Chengdu Origen") and Vanotech Ltd. ("Vanotech") announced today the first patient dosed in the...

United States Avner Ingerman Origen Vanotech Vanotech Ltd Prnewswire Chengdu Origen Biotechnology Co Ltd Retina Research At Ophthalmic Consultants Of Boston

Source: prnewswire.com

Chutes & Ladders—Pfizer's development leader is retiring in early 2022

October 8, 2021

Pfizer's chief development officer, Rod MacKenzie, is the Big Pharma's second executive to retire in early 2022. NIH Director Francis Collins will also hit the exit, before the end of this year. Sanofi poaches Gilead cancer executive Valeria Fantin to run its oncology research.

New York United States Karin Bultman Garth Kinberger Camille Mcmullen Robert Ashworth

Source: fiercebiotech.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Avner Ingerman News Today

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2201 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Chutes & Ladders&#x2014;Pfizer's development leader is retiring in early 2022

Explore More Categories

Chutes & Ladders—Pfizer's development leader is retiring in early 2022